We are updating our Privacy Policy and Terms and Conditions to help you clearly understand how your personal information is collected, stored and managed. Learn More
Menu Back to Event-Details

Life Cycle Management Activities of Drug Device Combinations

Track:
A New Era for Medical Devices and Diagnostics. How Is The Impact?

Day & Time:
April 19, 8:30AM - 10:00AM (Central Europe Standard Time)

Session Number:
S0704

Room Number:
Lima

Type:
Session

Title:
Life Cycle Management Activities of Drug Device Combinations

Chair(s):
Amanda Matthews
Director, Regulatory CMC
Pfizer, United Kingdom

Description:
Life Cycle Management Activities of Drug Device Combinations

Presentation(s) & Speaker(s):
Life Cycle Management of Combination Products from Development to Product Retirement
Mike Wallenstein, MSc
Executive Director QA
Novartis , Switzerland

Overcoming Regulatory Challenges within PFS and Auto Injector Development and Life Cycle Management
Vikas Jaitely
Associate Director
Merck, Switzerland

Life Cycle Challenges for On-Market Products
Cornelia Kruettli
Head of Product Care
F. Hoffmann-La Roche, Switzerland